scorecardresearch
Add as a preferred source on Google
Tuesday, April 7, 2026
TopicAjay Piramal

Topic: Ajay Piramal

Carlyle Group to buy 20% stake in Ajay Piramal’s pharmaceutical business

In addition to helping expand capacity of the pharmaceutical operations, the Piramal group will use the money to repay some of Piramal Enterprises Ltd.’s debt.

Even India’s biggest billionaires can’t escape the crunch in debt market

Ratings of some firms of billionaires Ajay Piramal, Pallonji Mistry & MP Lodha have been cut as the business environment worsened and funding costs rose.

Anand Piramal seeks to take advantage of India’s teetering property market

Piramal Realty is looking to buy land from distressed developers and build a portfolio of commercial assets.

Ajay Piramal plans to sell $1 billion contract pharma business

Piramal Pharma Solutions is a contract development & manufacturing organisation which is into drug discovery and commercial production.

On Camera

Syringes, MRI to ventilators, West Asia war squeezing India’s medical supply chain—costs up 10 to 50%

Industry says manufacturers have 2-4 weeks of buffer stocks, but prolonged disruption could push up shortage risks, especially of consumables like IV and syringes.

UAE walks away from financing Rafale F5 due to restricted access to technology, reports French media

French newspaper La Tribune earlier last week indicated that UAE withdrew from deal to fund EUR 3.5 billion. India is looking to order 114 new Rafales, which could include the F5.

China insulated itself against energy shocks. India is ‘all talk, no walk’

China patiently invested capital, skill and technology in coal gasification. Unlike it, we won’t move from words to action. As crude prices decline, we lose interest.